| Ms Julie S Plustache, LCSW | |
|
330 Oak Harbor Blvd, Suite A, Slidell, LA 70458-5702 | |
| (504) 616-5657 | |
| Not Available |
| Full Name | Ms Julie S Plustache |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 330 Oak Harbor Blvd, Slidell, Louisiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821310350 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 4367 (Louisiana) | Primary |
| Entity Name | Julie S Plustache Lcsw Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861732349 PECOS PAC ID: 4789051657 Enrollment ID: O20221106000019 |
News Archive
In the scientific article recently published in Scandinavian Journal of Child and Adolescent Psychiatry and Psychology, Erica Ramstad and others reviewed the existing evidence between various psychotic symptoms such as hallucinations, problems with concentration or anxiety with methylphenidate, a drug commonly prescribed as a treatment for attention deficit hyperactivity disorder and narcolepsy.
Omeros Corporation today announced additional positive data in the company's Phase 2 clinical trial of OMS721 for the treatment of thrombotic microangiopathies (TMAs). TMAs are a family of rare, debilitating and life-threatening disorders characterized by excessive thrombi (clots) – aggregations of platelets – in the microcirculation of the body's organs, most commonly the kidney and brain.
Simulations Plus, Inc., a leading provider of simulation and modeling software for pharmaceutical discovery and development, today reported preliminary revenues for its second quarter of fiscal year 2012 ended February 29, 2012 (2QFY12).
Dysfunction of the ubiquitin-proteasome system (UPS) has been detected in many neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases, and certain types of cancer. Such dysfunction is also believed to be related to some degenerative muscle diseases. Researchers at the University of Helsinki, Finland, have now discovered an important mechanism that regulates proteasome activity.
SQI Diagnostics Inc., a life sciences company that develops and commercializes proprietary multiplexing technologies and products for advanced microarray diagnostics, today announced its financial and operational results for the second quarter ended March 31, 2011.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Julie S Plustache, LCSW 330 Oak Harbor Blvd., Suite A, Slidell, LA 70458-5702 Ph: (504) 616-5657 | Ms Julie S Plustache, LCSW 330 Oak Harbor Blvd, Suite A, Slidell, LA 70458-5702 Ph: (504) 616-5657 |
News Archive
In the scientific article recently published in Scandinavian Journal of Child and Adolescent Psychiatry and Psychology, Erica Ramstad and others reviewed the existing evidence between various psychotic symptoms such as hallucinations, problems with concentration or anxiety with methylphenidate, a drug commonly prescribed as a treatment for attention deficit hyperactivity disorder and narcolepsy.
Omeros Corporation today announced additional positive data in the company's Phase 2 clinical trial of OMS721 for the treatment of thrombotic microangiopathies (TMAs). TMAs are a family of rare, debilitating and life-threatening disorders characterized by excessive thrombi (clots) – aggregations of platelets – in the microcirculation of the body's organs, most commonly the kidney and brain.
Simulations Plus, Inc., a leading provider of simulation and modeling software for pharmaceutical discovery and development, today reported preliminary revenues for its second quarter of fiscal year 2012 ended February 29, 2012 (2QFY12).
Dysfunction of the ubiquitin-proteasome system (UPS) has been detected in many neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases, and certain types of cancer. Such dysfunction is also believed to be related to some degenerative muscle diseases. Researchers at the University of Helsinki, Finland, have now discovered an important mechanism that regulates proteasome activity.
SQI Diagnostics Inc., a life sciences company that develops and commercializes proprietary multiplexing technologies and products for advanced microarray diagnostics, today announced its financial and operational results for the second quarter ended March 31, 2011.
› Verified 7 days ago
Mr. Eric Oleson, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1924 Corporate Square Dr, Slidell, LA 70458 Phone: 985-781-7476 | |
Cindy Cae Dahlstrom Mcnitt, MSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 119 Aberdeen Dr, Slidell, LA 70461 Phone: 985-641-7400 Fax: 985-641-4717 | |
Karell Brookins, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 330 Tiffany St, Slidell, LA 70461 Phone: 804-677-1016 | |
Ms. Leslie Mccoy, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 175 N Military Rd, Slidell, LA 70461 Phone: 985-640-8358 | |
Mr. Edward E Tedrow, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2238 First St., Slidell, LA 70458 Phone: 985-690-6622 | |
Joan Scanlan, LCSW Clinical Social Worker Medicare: May Accept Medicare Assignments Practice Location: 620 Oak Harbor Blvd Ste 101, Slidell, LA 70458 Phone: 985-710-7777 Fax: 985-276-3391 | |
Melanie Waguespack Cox, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 102 York Ct, Slidell, LA 70461 Phone: 985-788-7102 |